Early trial results in a pancreatic cancer vaccine show most patients mounting a strong immune response, raising hopes it could help keep the disease from coming back after treatment. The next big readout could be a turning point if the larger study confirms the benefit—and a setback if it doesn’t.Read more

It is almost impossible to obtain a drug label from the FDA for pediatric use - this topical non-steroidal drug ZORYVE is very safe and highly effective for both pediatric and adult patients. The drug is potent in the skin, it is not well absorbed and is quickly metabolized which limits systemic exposure and minimizes side effect risks.Read more